Jane Henderson will leave Voyager Therapeutics Inc. as CFO and senior vice president of corporate development on June 8.
Henderson is leaving to pursue other career opportunities that are closer to her home, according to the company.
The Cambridge, Mass.-based clinical-stage gene therapy company said its vice president finance, Allison Dorval, will assume the roles of principal financial officer and principal accounting officer.
